ABC | Volume 110, Nº4, April 2018

Original Article Cartolano et al LAP and lipoprotein size Arq Bras Cardiol. 2018; 110(4):339-347 This is an open-access article distributed under the terms of the Creative Commons Attribution License 26. Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab (Seoul). 2014;29(4):443-9. doi: 10.3803/EnM.2014.29.4.443. 27. Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, et al. Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J. 2006; 47(3): 405-14. doi: 10.3349/ymj.2006.47.3.405. 28. Shen H, Xu L, Lu J, Hao T, Ma C, Yang H, et al. Correlation between small dense low-density lipoprotein cholesterol and carotid artery intima-media thickness in a healthy Chinese population. Lipids Health Dis. 2015 Oct 29;14:137. doi: 10.1186/s12944-015-0143-x. 29. Toth PP, Patti AM, NikolicD, Giglio RV, CastellinoG, Biancucci T, et al. Bergamot reducesplasmalipids,atherogenicsmalldenseLDL,andsubclinicalatherosclerosis in subjects withmoderate hypercholesterolemia: a 6months prospective study. FrontPharmacol.2016Jan6;6:299.doi:10.3389/fphar.2015.00299. 30. ShenH, Zhou J, Shen G, Yang H, Lu Z, Wang H. Correlation between serum levels of small, dense low-density lipoprotein cholesterol and carotid stenosis in cerebral infarction patients >65 years of age. Ann Vasc Surg. 2014;28(2):375-80. doi: 10.1016/j.avsg.2013.01.029. 31. Eppinga RN, Hartman MH, van Veldhuisen DJ, Lexis CP, Connelly MP, Lipsic E, et al. Effect of metformin treatment on lipoprotein subfractions in non-diabetic patients with acute myocardial infarction: a glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial. PLoS One. 2016;11(1):e0145719. doi: 10.1371/journal.pone.0145719. 32. Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence inmale participants of the FraminghamOffspring Study. Arterioscler Thromb Vasc Biol. 2004;24(11):2181-7. doi: 10.1161/01. ATV.0000146325.93749.a8. 33. O’Neill F, McLoughlin E, Riwanto M, Manz J, Adler A, Sutill E, et al. Reproducibility and biological variability of HDL’s vascular functional assays. Atherosclerosis. 2015;241(2):588-94. doi: 10.1016/j. atherosclerosis.2015.06.005. 34. El Harchaoui K, Arsenault BJ, Franssen R, Despres JP, HovinghGK, Stroes ES, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009;150(2):84-93. doi: 10.7326/0003-4819-150- 2-200901200-00006. 35. Pankow JS, Duncan BB, SchmidtMI, BallantyneCM, Couper DJ, Hoogeveen RC, et al. Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2004;27(1):77-82. doi: https://doi.org/10.2337/diacare.27.1.77. 36. Il’yasova D, Wang F, D’Agostino RB Jr, Hanley A, Wagenknecht LE. Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia. 2010;53(5):8668-74. doi: 10.1007/ s00125-010-1657-4. 37. Sarafidis PA, Bakris GL. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/ insulin resistance? J Hum Hypertens. 2007;21(1):12-9. doi: 10.1038/ sj.jhh.1002103 38. Djoussé L, Biggs ML, Ix JH, Kizer JR, Lemaitre RN, Sotoodehnia N, et al. Nonesterified fatty acids and risk of sudden cardiac death in older adults. Circ ArrhythmElectrophysiol.2012;5(2):273-8.doi:10.1161/CIRCEP.111.967661. 39. Morita S, Shimajiri Y, Sakagashira S, Furuta M, Sanke T. Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes: a long-term follow-up study. Diabet Med. 2012;29(8):980-5. doi: 10.1111/j.1464-5491.2011.03566.x. 40. Sambataro M, Perseghin G, Lattuada G, Beltramello G, Luzi L, Pacini G. Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines. Acta Diabetol. 2013; 50(3): 301-7. doi: 10.1007/s00592-011-0366-x. 347